"La táctica es saber qué hay que hacer cuando hay que hacer algo; la estrategia consiste en saber qué hacer cuando no hay que hacer nada".
Genialidad del gran maestro polaco Savielly Tartakower, guía muy útil.
"La táctica es saber qué hay que hacer cuando hay que hacer algo; la estrategia consiste en saber qué hacer cuando no hay que hacer nada".
Springer Acquires BioMed Central Group
In October 2008 Springer announced the acquisition of BioMed Central Group (BMC), the leading global open access publisher.
Launched in May 2000 as an independent publishing house committed to providing free access to peer-reviewed research in the biological and medical sciences, BMC is the largest open access provider in the world with over 180 peer-reviewed journals. BioMed Central’s flagship journals include Journal of Biology, BMC Biology, BMC Medicine, Malaria Journal, BMC Bioinformatics and Genome Biology.
Derk Haank, CEO of Springer said: "This acquisition reinforces the fact that we see open access publishing as a sustainable part of STM publishing, and not an ideological crusade. We have gained considerable positive experience since starting Springer Open Choice in 2004, and BioMed Central's activities are complementary to what we are doing. Additionally, this acquisition strengthens Springer’s position in the life sciences and biomedicine, and will allow us to offer societies a greater range of publishing options."